In summary, we demonstrated that hypoxic BMSC‐derived EVs could deliver miR‐328‐3p to target the NF2 gene, which inhibited the Hippo pathway, thereby promoting the occurrence and progression of lung cancer (Figure 8). Here, NF2 is linked to lung cancer.